Prezista Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

prezista

janssen-cilag international nv - darunavir - hiv Λοιμώξεις - Αντιιικά για συστηματική χρήση - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.

NEVALAN 20MG GASTRO RESISTANT TABLET Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

nevalan 20mg gastro resistant tablet

remedica ltd (0000003171) aharnon str., lemesos, 3056 - esomeprazole magnesium dihydrate - gastro resistant tablet - 20mg - esomeprazole magnesium dihydrate (8000003978) 21.69mg - esomeprazole

REPRAT 40MG GASTRO RESISTANT TABLET Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

reprat 40mg gastro resistant tablet

delorbis pharmaceuticals ltd (0000009620) 17 athinon street, ergates industrial area, lefkosia, 2081, 28629 - pantoprazole sodium sesquihydrate - gastro resistant tablet - 40mg - pantoprazole sodium sesquihydrate (8000001653) 45,15mg - pantoprazole

KORTIKERAL® CUT.SOL (0.2+2.0)% (W/W) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

kortikeral® cut.sol (0.2+2.0)% (w/w)

verisfield ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε. Δ.Τ. verisfield Βύρωνος 8 & Γυθείου, Χαλάνδρι 152 31 210.7475196 - triamcinolone acetonide; salicylic acid - cut.sol (ΔΕΡΜΑΤΙΚΟ ΔΙΑΛΥΜΑ) - (0.2+2.0)% (w/w) - triamcinolone acetonide 0,2%; salicylic acid 2% - other antipsoriatics for topical use

KORTIKERAL® GEL (0.2+2.0)% (W/W) Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

kortikeral® gel (0.2+2.0)% (w/w)

verisfield ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε. Δ.Τ. verisfield Βύρωνος 8 & Γυθείου, Χαλάνδρι 152 31 210.7475196 - triamcinolone acetonide; salicylic acid - gel (ΓΕΛΗ) - (0.2+2.0)% (w/w) - triamcinolone acetonide 0,2%; salicylic acid 2% - other antipsoriatics for topical use

LYMPHOMYOSOT® TAB (15+15+15+15+15+15+15+15+15+15+15+15+15+15+30+30+30)MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

lymphomyosot® tab (15+15+15+15+15+15+15+15+15+15+15+15+15+15+30+30+30)mg/tab

biologische heilmittel heel gmbh, germany dr. reckeweg stra. 2-4, 76532 baden-baden +49 7221 501-00 - araneus diadematus; calcium phosphate tribasic; equisetum; fumaria officinalis; gentiana lutea; juglans regia; levothyroxine; myosotis arvensis; sodium sulfate anhydrous; pinus silvestris; scrophularia nodosa; smilax officinalis; teucrium scorodonia; veronica officinalis; ferrous iodide; geranium robertianum; nasturtium officinale - tab (ΔΙΣΚΙΟ) - (15+15+15+15+15+15+15+15+15+15+15+15+15+15+30+30+30)mg/tab - araneus diadematus 15mg; calcium phosphate tribasic 15mg; equisetum 15mg; fumaria officinalis 15mg; gentiana lutea 15mg; juglans regia 15mg; levothyroxine 15mg; myosotis arvensis 15mg; sodium sulfate anhydrous 15mg; pinus silvestris 15mg; scrophularia nodosa 15mg; smilax officinalis 15mg; teucrium scorodonia 15mg; veronica officinalis 15mg; ferrous iodide 30mg; geranium robertianum 30mg; nasturtium officinale 30mg

TRAUMEEL® S OINTMENT Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

traumeel® s ointment

biologische heilmittel heel gmbh, germany dr. reckeweg stra. 2-4, 76532 baden-baden +49 7221 501-00 - achillea millefolium; aconitum napellus; arnica montana; atropa belladona; bellis perennis; calendula officinalis; echinacea; echinacea purpurea; hamamelis virginiana; hepar sulfuris; hypericum perforatum; matricaria recutita; mercurius solubilis hahnemanni; symphytum officinale - ointment (ΑΛΟΙΦΗ) - achillea millefolium 0,09g; aconitum napellus 0,05g; arnica montana 1,5g; atropa belladona 0,05g; bellis perennis 0,1g; calendula officinalis 0,45g; echinacea 0,15g; echinacea purpurea 0,15g; hamamelis virginiana 0,45g; hepar sulfuris 0,025g; hypericum perforatum 0,09g; matricaria recutita 0,15g; mercurius solubilis hahnemanni 0,04g; symphytum officinale 0,1g - not yet assigned

CANEPHRON® UNO C.TAB (36+36+36)MG/TAB Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

canephron® uno c.tab (36+36+36)mg/tab

bionorica se, germany kerschensteinerstrasse 11-15, 92318 bavaria +49/9181/231-234 - herba centauri; levisticum officinale; rosmarinus officinalis - c.tab (ΕΠΙΚΑΛΥΜΜΕΝΟ ΔΙΣΚΙΟ) - (36+36+36)mg/tab - herba centauri 36mg; levisticum officinale 36mg; rosmarinus officinalis 36mg

ECHINAFORCE PLUS® MOUTH SPR (863.3+45.5+430)MG/ML Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

echinaforce plus® mouth spr (863.3+45.5+430)mg/ml

healthcode ike, Δ.Τ. healthcode, ΕΛΛΑΔΑ 13 Μενεμένης, 17778 Ταύρος - echinacea purpurea; echinacea purpurea; salvia officinalis - mouth spr (ΣΤΟΜΑΤΙΚΟ ΕΚΝΕΦΩΜΑ) - (863.3+45.5+430)mg/ml - echinacea purpurea 863,3mg; echinacea purpurea 45,5mg; salvia officinalis 430mg

BRONCHONIGHT® ORAL.SOL (12.5+9.09+10.0)MG/ML Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

bronchonight® oral.sol (12.5+9.09+10.0)mg/ml

kwizda pharma gmbh, wien, austria effingergasse 21,, a-1160, wien - althaea officinalis; lime flower dry extract; ribwort plantain dry extract - oral.sol (ΠΟΣΙΜΟ ΔΙΑΛΥΜΑ) - (12.5+9.09+10.0)mg/ml - althaea officinalis 12,5mg; lime flower dry extract 9,09mg; ribwort plantain dry extract 10mg - combinations